curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 13,770
-200 (-1.43%)
At close: Apr 9, 2026
curacle co.,ltd. Revenue
In the year 2025, curacle co.,ltd. had annual revenue of 7.10M KRW, down -99.57%. curacle co.,ltd. had revenue of -10.00 in the quarter ending December 31, 2025.
Revenue
7.10M
Revenue Growth
-99.57%
P/S Ratio
41,789.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
296.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.10M | -1.63B | -99.57% |
| Dec 31, 2024 | 1.63B | -8.66B | -84.14% |
| Dec 31, 2023 | 10.29B | 6.71B | 187.32% |
| Dec 31, 2022 | 3.58B | -2.67B | -42.72% |
| Dec 31, 2021 | 6.25B | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 100.17B |
| ISU Abxis | 56.67B |
| NIBEC | 32.72B |
| Genome & Company | 24.59B |
| S.Biomedics | 16.55B |
| Bio Solution | 15.20B |
| TiumBio | 12.29B |
| Kangstem Biotech | 3.57B |